Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI.
Saved in:
| Title: | Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI. |
|---|---|
| Authors: | Hye Ryeon Kim1,2, Hyunji Jo1, Hongsik Kim1, Joohyun Hong1, Sehhoon Park1, Hyun Ae Jung1, Se-Hoon Lee1, Jin-Seok Ahn1, Myung-Ju Ahn1 |
| Source: | Cancer Research & Treatment. Jan2023, Vol. 55 Issue 1, p344-349. 6p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 161352571 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hye+Ryeon+Kim%22">Hye Ryeon Kim</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Hyunji+Jo%22">Hyunji Jo</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Hongsik+Kim%22">Hongsik Kim</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Joohyun+Hong%22">Joohyun Hong</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Sehhoon+Park%22">Sehhoon Park</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Hyun+Ae+Jung%22">Hyun Ae Jung</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Se-Hoon+Lee%22">Se-Hoon Lee</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Jin-Seok+Ahn%22">Jin-Seok Ahn</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Myung-Ju+Ahn%22">Myung-Ju Ahn</searchLink><relatesTo>1</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Research+%26+Treatment%22">Cancer Research & Treatment</searchLink>. Jan2023, Vol. 55 Issue 1, p344-349. 6p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=161352571 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.4143/crt.2021.1603 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 344 Titles: – TitleFull: Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hye Ryeon Kim – PersonEntity: Name: NameFull: Hyunji Jo – PersonEntity: Name: NameFull: Hongsik Kim – PersonEntity: Name: NameFull: Joohyun Hong – PersonEntity: Name: NameFull: Sehhoon Park – PersonEntity: Name: NameFull: Hyun Ae Jung – PersonEntity: Name: NameFull: Se-Hoon Lee – PersonEntity: Name: NameFull: Jin-Seok Ahn – PersonEntity: Name: NameFull: Myung-Ju Ahn IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 15982998 Numbering: – Type: volume Value: 55 – Type: issue Value: 1 Titles: – TitleFull: Cancer Research & Treatment Type: main |
| ResultId | 1 |
